Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a ...

The 5th mRNA-Based Therapeutics Summit Europe is the leading European industry-focused forum dedicated to accelerating the ...

A survey of frontline NHS workers has found that almost two-thirds (61%) feel they are unprepared for the digital ...

Eli Lilly's fast-growing blood cancer drug Jaypirca has bagged a new FDA approval as an earlier treatment for relapsed or ...

In a recent blog post, the PhRMA industry organisation said that the PDUFA system is "essential to America's edge in drug ...

Bayer has started a phase 2a trial of an antibody that it hopes could provide a targeted, potentially disease-modifying ...

For decades, contract development and manufacturing organisations (CDMOs) have operated through fragmented models, with drug ...

FDA Commissioner Marty Makary has appointed Tracy Beth Høeg as acting director of the Center for Drug Evaluation and Research ...

These days, the phrase “omnichannel engagement” is everywhere. But the way the biopharmaceutical industry thinks about ...

The FDA has now started a review of the highly anticipated drug, and AZ is using a priority review voucher to shorten the ...

The FDA estimates that a typical non-clinical programme with a monoclonal antibody product could include more than 100 NHPs, ...

VTx-002 is described as a first-in-class vectorised antibody targeting molecular pathways involving TAR DNA-binding protein ...